Geneva will marry up the world’s leading investors, executives and entrepreneurs with scientists and researchers of the brain and nervous system at the 3rd European Neurotech Investing & Partnering Summit 2015.
Held in September, the event is the premier partnering and investing conference for the neurotechnology industry, incorporating pharmaceuticals, medical devices, software and diagnostics for the brain and nervous system.
The host city will not have to look far for expert speakers and qualified attendees: the biotech and medtech sectors in BioAlps, the most diversified life science cluster in the world, are experiencing double-digit annual growth. This fast-growing cluster within Western Switzerland employs 25,000 people and comprises 750 companies, including multinationals Baxter, Debiopharm and UCB Farchim. Specialist incubators like Eclosion and Fongit combine with Geneva’s favourable conditions and tax incentives to support new businesses and start-ups.
Science magazine has called the Lake Geneva Region the ‘Number One cluster for life sciences research in continental Europe’, with 20 research institutions and universities driving Geneva’s cutting-edge research in pharmaceuticals, chemistry, biotechnology, microtechnology, precision instruments and medical devices.
The University of Geneva is host to three National Centers of Competence in Research (NCCR): Materials with novel electronic properties (electronic materials for the future, which might be used in bioconvergent applications); Affective Sciences, and Frontiers in Genetics. Meanwhile, its Institute of Genetics and Genomics in Geneva (iGE3) pulls together 50 research groups in the field of Genome Sciences.
The Geneva Medical School hosts 370 research groups, while Geneva is one of the 3 Clinical Trial Units, together with Basel and Bern, recognised by the Swiss National Fund.
Geneva’s Campus Biotech works as a central hub in the life science realm, bringing together both entrepreneurship and academia by hosting research institutes and biotechnology companies, with a focus on rare and orphan diseases, neurology and immunology. The Human Brain Project, the Bertarelli Professorships in Translational Neuroscience and the new Wyss Center for Bio- and Neuro-Engineering are among the projects located at the hub.
It is also proving pivotal in global life science work: This month Campus Biotech hosted the EUFEPS Annual Meeting 2015, bringing together representatives of pharmaceutical sciences in industry, academia and regulatory agencies to exchange strategies for the development of better medicines.
Featured image from the BioAlps Lake Geneva Life Sciences Cluster (CC BY-NC-ND 2.0)